Carboplatin-Paclitaxel vs Cisplatin-Etoposide With Thoracic Radiation for NSCLC
This systematic review compares outcomes and toxic effects between thoracic radiation with either cisplatin-etoposide or carboplatin-paclitaxel for patients with stage III non–small-cell lung cancer.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου